🔎 Trials Near Me

Domov › Shizofrenija › Florida

Klinične študije za Shizofrenija v Florida

26 študij za Shizofrenija išče udeležence na lokacijah v Florida.

Mesta v Florida

Uradno besedilo študije (angleško)

Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

  • Local Institution - 0019, Miami
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07101094

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

  • Research Centers of America ( Hollywood ), Hollywood
  • Local Institution - 0195, Oakland Park
  • Health Synergy Clinical Research, West Palm Beach
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07686263

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

  • Sarkis Clinical Trials, Gainesville
  • United Research Institute, Hialeah
  • Advanced Research Institute of Miami, Homestead
  • in še 13
Vključevanje udeležencevFaza 3
Starost 5–17 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06229210

NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

  • Neurocrine Clinical Site, Hollywood
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07105098

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

  • Neurocrine Clinical Site, Atlantis
  • Neurocrine Clinical Site, Aventura
  • Neurocrine Clinical Site, Hollywood
  • in še 5
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07114874

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

  • Neurocrine Clinical Site, Hollywood
  • Neurocrine Clinical Site, Maitland
  • Neurocrine Clinical Site, Miami
  • in še 3
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07227818

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

  • Local Institution - 0145, Boca Raton
  • Local Institution - 0160, Gainesville
  • Local Institution - 0164, Gainesville
  • in še 2
Vključevanje udeležencevFaza 3
Starost 5–17 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07424404

A Study of Brenipatide in Adult Participants With Schizophrenia

  • Magno Medical Research Group, Cooper City
  • NextPhase Research Florida - Hollywood, Hollywood
  • Innovative Clinical Research, Lauderhill
  • in še 5
Vključevanje udeležencevFaza 2
Starost 18–55 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07410507

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

  • Neurocrine Clinical Site, Bonita Springs
  • Neurocrine Clinical Site, Hialeah
  • Neurocrine Clinical Site, Miami
  • in še 3
Vključevanje udeležencevFaza 4
Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT07105111

A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia

  • University Clinical Research-DeLand, LLC d/b/a Accel Research Sites - DeLand Clinical Research Unit, DeLand
  • Behavioral Clinical Research, Inc., Hollywood
  • CenExel Hollywood FL, Hollywood
  • in še 1
Vključevanje udeležencevFaza 1
Starost 18–55 · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07734493

52-week Open Label Safety-Tolerability Study

  • CenExel, Hollywood
  • Segal Trials, Miami Lakes
  • Health Synergy Clinical Research, West Palm Beach
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07369154

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

  • Local Institution - 0119, Hollywood
  • Apg Research, Llc, Orlando
Vključevanje udeležencevFaza 3
Starost 13–17 · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07288567

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

  • Research Centers of America ( Hollywood ), Hollywood
  • Innovative Clinical Research, Inc., Miami Lakes
Vključevanje udeležencevFaza 1
Starost 18–55 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07061288

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

  • Clinical Site, Hollywood
  • Clinical Site, Hollywood
  • Clinical Site, Miami
  • in še 2
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT07459647

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

  • Envision Trials LLC, Bonita Springs
  • Galiz Research, Hialeah
  • Local Institution - 0030, Homestead
  • in še 7
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT07379827

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

  • Alkermes Investigator Site, Miami Lakes
Vključevanje udeležencevFaza 3
Starost 10–17 · Vsi spoli · Posodobljeno 14. avg. 2026 · NCT05303064

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

  • Bioxcel Clinical Research Site, Hialeah
Vključevanje udeležencevFaza 1
Starost 10–17 · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT05025605

Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia

  • Segal Institute for Clinical Research, Miami
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 29. jul. 2026 · NCT07467993

Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia

  • Health Synergy Clinical Research, Boynton Beach
  • Innovative Clinical Research, Miami Lakes
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 27. jul. 2026 · NCT07363577

A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

  • NeuroBehavioral Hospitals of the Palm Beaches - South, Boynton Beach
  • Cenexel RCA, Hollywood
Vključevanje udeležencevFaza 2
Starost 18–55 · Vsi spoli · Posodobljeno 23. jun. 2026 · NCT07191483

A Study to Evaluate the Effect of KarXT on Urological Safety

  • Innovative Clinical Research, Lauderhill
  • Health Synergy Clinical Research, West Palm Beach
Vključevanje udeležencevFaza 4
Starost 18–65 · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT07221877

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

  • Neurocrine Clinical Site, Hollywood
  • Neurocrine Clinical Site, Miami Lakes
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 6. mar. 2026 · NCT06963034

Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy

  • University of Miami, Miami
Vključevanje udeležencev
Starost 18–65 · Vsi spoli · Posodobljeno 23. jan. 2026 · NCT07098169

Randomized Withdrawal Study in Patients With Schizophrenia

  • Vanda Investigational Site, North Miami
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 12. jan. 2026 · NCT06961968

Study of ALTO-101 in Patients With Schizophrenia

  • Site 5060, Hollywood
  • Site 5015, Tampa
Vključevanje udeležencevFaza 2
Starost 21–55 · Vsi spoli · Posodobljeno 26. dec. 2025 · NCT06502964

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

  • Reviva site, Hollywood
  • Reviva site, Hollywood
  • Reviva site, Miami Lakes
Vključevanje udeležencevFaza 3Vabljeni zdravi prostovoljci
Starost 18–65 · Vsi spoli · Posodobljeno 19. dec. 2024 · NCT05184335

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.